Consensus Statements of the American College of Veterinary Internal Medicine (ACVIM) provide the veterinary community with up-to-date information on the pathophysiology, diagnosis, and treatment of clinically important animal diseases. The ACVIM Board of Regents oversees selection of relevant topics, identification of panel members with the expertise to draft the statements, and other aspects of assuring the integrity of the process.
No experimental model to study its pathogenesis, treatment, and prevention in over-represented (retriever) breeds has been developed, and no validated staining techniques are available to prove that glomerular immune-complexes are Lyme-specific in kidney biopsy specimens from living dogs. Despite these limitations, strategies for empirical management of Lyme nephritis are given, as recently offered by the International Renal Interest Society (IRIS) Glomerular Disease Study Group. [2] [3] [4] [5] The objectives of this consensus statement are to review the evidence and provide findings and recommendations that address these topics regarding Borrelia spp. infection in dogs or cats: 
| TOP I C 1 : WHA T S PE CI E S A RE M OS T COM M ON A ND WH ER E AR E TH E E N DE M I C A RE A S?
2.1 | Topic 1a: Update on Borrelia spp. and associated ticks
There are at least 52 Borrelia species, 6 including 21 in the LB group (B. burgdorferi sensu lato; Bb-sl; these gram-negative spirochetes generally migrate within the host interstitially), 29 in the relapsing fever group (migrating hematogenously), and 2 undetermined members. In dogs residing in North America, LB has only been associated with B.
burgdorferi sensu stricto (Bb), of which at least 30 subtypes or strains exist, based on outer surface protein C (OspC) genotyping. 7 The strains appear host-specific; different strains are more common in people as compared with dogs. 7, 8 In Europe, coinfections of Bb with other Bb-sl strains (ie, B. garinii) may predispose dogs to illness. 9 Other Bb-sl species causing human LB (ie, B. mayonii 10 
| TOP I C 3 : WHA T D I A GN OS TI C T ES TS TO CON FI R M Bb E XP OS U RE A R E RE CO M M E ND ED F O R CL I NI CA L LY I LL A NI M A LS?

| Topic 3a
In dogs, serology is the only recommended modality to evaluate for exposure to Bb (Table 2) . Validated serologic tests for Bb exposure in
North America include in-house and reference laboratory C 6 -based 
| Topic 3b
In cats, several studies document antibodies against Bb occur in the serum of cats that are naturally exposed or infected with Bb after being experimentally infested with I. scapularis. 75 In 1 of the studies, skin biopsy specimens also were tested for Bb DNA by PCR assay and 3 of 9 cats were PCR positive but remained C 6 antibody negative over the 84-day study. Many antibiotics, used both parenterally and PO, show efficacy in treating LB (Table 3) . 69, 98 Beta-lactams and tetracyclines have been shown to be effective for lessening clinical signs of LB in dogs.
Because of the protracted biological behavior of Borrelia, a long course of antibiotics (4 weeks Another relative contraindication is a breed with known inherited glomerulopathy.
The IRIS Study Group recommended mycophenolate as the first immunosuppressive employed, perhaps with a tapering dose of prednisolone in dogs with acute rapidly progressive glomerular disease. 4 To minimize adverse effects of glucocorticoids, they should not be the sole agent and should be tapered as quickly as possible. Other immunosuppressive drugs (Table 4) 
| Topic 4c
Because borreliosis in cats has never been confirmed in a single cat, the optimal treatment plan is unknown. In cats with suspected anaplasmosis, clinical signs rapidly resolve after doxycycline is administered at 5 mg/kg q12h or 10 mg/kg PO q24h for 14-28 days. 77, 78 Whether or not these cats also were infected with Bb cannot be determined. Based on studies of acute borreliosis in dogs, these doxycycline protocols are likely to be effective in cats as well.
| T OP IC 5: WH A T TE STI N G I S R EC OM M EN DE D F OR H E AL TH Y A N I M AL S?
Panelists ( 
| TO P I C 6 : S HO U L D TR EA TM E NTS BE OF FE RE D F OR N ON CLI N I CA L, NON P R OTEI N U R IC SER OP OSI TI V E DOG S?
This topic is still controversial; 4/6 panelists do not routinely recommend treatment for such dogs (Table 5) , 96, 124 stating that: (1) There is no ability to monitor the response to treatment if the dog is truly nonclinical; the vast majority of Bb-seropositive dogs never become ill nor proteinuric Unnecessary owner cost Overuse of antibiotics may cause microbial resistance in the environment at large Possible adverse effects of treatment Possible laxity in checking for proteinuria in carriers, even though they may not all be cleared with treatment Theoretically, a subclinically infected dog may be in a premunitive state that could be protective, at least for that particular strain reduction is considered acceptable as compared with being indication for continued treatment in the absence of clinical signs. The argument for treating until Quant C 6 results wane by at least 50% is that the organism may never be cleared as it enters "protected" collagen tissue, and 
| T OP IC 7: WH A T P RE V EN TI ON M OD A LI TI E S A RE R EC OMM E N DE D?
| Topic 7a: Tick control
Prevention of Bb infection and development of LB is multifaceted. The simplest and yet the most difficult step to achieve is tick prevention.
Ticks and the wildlife that carry ticks are in ever increasing proximity to dogs and people. Frequent tick checks and removing ticks as soon as they are identified is of utmost importance, although difficult in pets with long or dark hair. Perimeter control is equally important. Ixodes scapularis preferentially live under hardwood forest canopy and in the underlying leaf litter. [125] [126] [127] [128] At least in the home environment, minimizing chances for tick inhabitation means keeping lawns cut short, cleaning areas of brush and weeds, and using wood chips in gardens. [130] [131] [132] [133] [134] ) or a relatively fast kill after attachment (eg, with isoxazoline products [135] [136] [137] [138] [139] ) is preferred over use of fipronil, which does not kill the tick until after it has been attached for 24 hours. Fluralaner killed almost 90% of ticks by 4 hours, 98% by 8 hours, and 100% at 12 hours after application. 139 Tick collars should be applied tightly enough to have contact with skin, not just hair. Topical permethrins should not be used on or near cats. The new PO (hydrolysate chewable) isoxazoline products, which kill at least some of the tick species studied to date within 8 hours of attachment by binding to tick-specific neurotransmitter gamma-aminobutyric acid-gated chloride channels which mammals do not have, are easy to administer, increase compliance, and may help coverage for dogs that swim or get bathed often. 140, 141 Combinations of products with different mechanisms also may be used. See Table 6 for a comparison of some commonly used tick control products.
In 1 study of 9 cats infested with wild-caught I. scapularis twice, 2 cats seroconverted after the first infestation, became seronegative, and then seroconverted again after the second infestation suggesting a new primary infection. 76 Thus, it appears that Bb infection does not induce preventive immunity in cats and repeated infection can occur without tick control. In another study of naturally exposed cats with and without clinical signs referable to borreliosis, whether or not the owner purchased a tick control product was recorded. 142 When serum antibodies against Bb and A. phagocytophilum were measured, it was shown that purchase of a tick control product did not lessen the likelihood of detecting serum antibodies. Whether this finding related to lack of efficacy or failure of compliance could not be determined from the study. In dogs, use of tick control products appropriately can lessen the risk of developing antibodies against Bb and A. phagocytophilum, and this is likely to occur in cats as well if the products are used as directed. 135, 137, 143 Statement: Whether Bb vaccines are used or not, there is strong consensus that tick control must be used not only to help prevent LB but also to prevent many other TBDs for which there are no vaccines available [EBM-C].
| Topic 7b: Bb vaccination
The efficacy of tick control products is excellent, as proven by prevention of seroconversion after tick exposure challenge. 135, 137, 143 However, compliance for using these products properly is an ongoing problem, and many veterinarians in Bb-endemic areas also recommend ability of the spirochete to "hide" from the immune system in synovial membranes, down-regulating their immunogenic surface proteins, 152 and because of the existence of many strains for which there is no cross-reacting immunity. 
| SU M M A RY
Our panel achieved consensus on evaluating all dogs at risk in North America with a qualitative Bb antibody assay, testing all Bb-seropositive dogs for proteinuria, using doxycycline as the first choice for dogs or cats with suspected clinical LB (although the best protocol and duration are unknown), using mycophenolate with or without prednisone in Lyme nephritis suspects that are not responding to standard care, and using tick control for all dogs and cats at risk (Table 8) . Consensus was not reached on whether to treat all Bb-seropositive dogs and cats, 
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